APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Apyx Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.42−0.13 (-5.10%)
Close on Oct 19, 2026
- Market cap
- $106.12M
- P/E (TTM)
- –
- Dividend yield
- –
Apyx Medical Corp revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Aesthetics [Member] | $50.90M | $48.18M | $45.33M | $40.72M | $38.94M | – | $38.61M | – | – | – | – | – | 87.1% | +30.7% |
| OEM [Member] | $7.52M | $7.73M | $7.51M | $7.18M | $7.57M | $8.25M | $9.50M | $9.90M | $9.84M | – | $8.97M | – | 12.9% | -0.6% |
| OEM | – | – | – | – | – | – | – | – | $9.84M | $9.31M | $8.97M | $8.51M | – | – |
| Advanced Energy [Member] | – | – | – | – | $38.94M | $39.04M | $38.61M | $38.64M | $39.19M | $41.15M | $43.38M | $41.79M | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Aesthetics [Member] | $9.86M | $8.66M | $6.69M | $3.79M | $1.42M | – | -$3.89M | – | – | – | – | – | +592.1% |
| OEM [Member] | $2.24M | $2.21M | $1.86M | $1.35M | $1.05M | $1.33M | $1.97M | $2.30M | $2.51M | – | $2.52M | – | +112.6% |
| OEM | – | – | – | – | – | – | – | – | $2.51M | $2.41M | $2.52M | $2.29M | – |
| Advanced Energy [Member] | – | – | – | – | $1.42M | -$934.00K | -$3.89M | -$5.11M | -$4.71M | -$2.42M | -$956.00K | -$1.29M | – |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $41.80M | $40.17M | $38.80M | $34.41M | $32.88M | $33.79M | $34.02M | $34.14M | $35.00M | $36.45M | $38.35M | $36.38M | 71.6% | +27.2% |
| Non-US [Member] | $16.61M | $15.73M | $14.04M | $13.49M | $13.64M | $13.50M | $14.08M | $14.40M | $14.03M | $14.00M | $14.00M | $13.92M | 28.4% | +21.8% |
From the segment and revenue-disaggregation notes of Apyx Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.